Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Jean Perrin
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Age \> or = 18 years
performance status WHO \< 2
Epithelial ovarian, fallopian tubes or primary peritoneal carcinoma (histologically confirmed)
Unresectable disease because of FIGO stage IV disease proven by imaging (CT Scan or PET CT) and/or diffuse extensive carcinosis considered unresectable for advanced FIGO stage IIIc; or patients unable to support a radical primary surgery because of age, comorbidities or altered general condition.
No previous debulking surgery before neoadjuvant chemotherapy.
Patients treated with a minimum of 3 cycles of platinum-based neoadjuvant chemotherapy.
Response to chemotherapy was radiologically confirmed (Scan-TAP) prior to interval surgery:
No evidence of peritoneal supra-mesocolic carcinomatosis ; Residual pelvic masses smaller than 10 cm ; Absence of suspect supra-centimeter retroperitoneal lymphadenopathy
able to read, write and understand French.
Member of a Social Security scheme.
written informed consent.
You may not be if
Patient unable to support laparoscopy
psychiatric condition or social or geographic situation that would impede appropriate study participation
Concomitant participation in another clinical trial evaluating surgical treatment (interfering with the evaluation of the main endpoint)
Clareo Health | Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive Patients
